Protalix BioTherapeutics logo
Protalix BioTherapeutics PLX
$ 1.71 2.71%

Quarterly report 2024-Q3
added 11-14-2024

report update icon

Protalix BioTherapeutics Total Current Liabilities 2011-2024 | PLX

Annual Total Current Liabilities Protalix BioTherapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
45.5 M 32.4 M 33.2 M 86.5 M 40.2 M 25.4 M 22.8 M 66.2 M 11.2 M 26.2 M 26.7 M 25.8 M 18.7 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
86.5 M 11.2 M 35.4 M